The change rate in serum nitric oxide may affect lenvatinib therapy in hepatocellular carcinoma.
Kawamura A, Uojima H, Chuma M, Shao X, Hidaka H, Nakazawa T, Take A, Sakaguchi Y, Numata K, Kako M, Nozaki A, Azuma S, Horio K, Kusano C, Atsuda K.
Kawamura A, et al. Among authors: atsuda k.
BMC Cancer. 2022 Aug 23;22(1):912. doi: 10.1186/s12885-022-10002-x.
BMC Cancer. 2022.
PMID: 35999529
Free PMC article.